← All stocks

PRECISION BIOSCIENCES INC

DTIL Net buying
CIK 0001357874 #3786 in the set updated 18 Sep 2026
Bought (120 mo)
$2.12M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.59M
$922.34K on a plan · $4.14M straight out of an exercise
Sold at will
$523.94K
15 of 80 sales
Net
−$3.47M
+$1.60M against sales at will

By person

21 insiders · 119 transactions
1.4×

Michael Amoroso holds only 1.4 times base salary in stock. $934.63K of shares against $650.88K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Amoroso last reported holding, valued at $3.84, the price Common Stock was last bought or sold at on the open market here, on 18 Feb 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
JANTZ DEREK
Chief Scientific Officer
$1.62M (17) scheduled
−$1.62M
4,055,174
$15.57M
+5.5%
KANE MATTHEW R.
President and CEO
$1.61M (15) scheduled
−$1.61M
2,024,438
$7.77M
+11.0%
THOMSON DAVID S.
Chief Operating Officer
$1.24M (7) scheduled
−$1.24M
111,513
$428.21K
+2,434%
FMR LLC entity
See Remark 1
$800.00K (1)
+$800.00K
3,738,248
$14.35M
venBio Global Strategic Fund, L.P. entity
Director
$800.00K (1)
+$800.00K
4,265,141
$16.38M
Amoroso Michael
President and CEO
$616.53K (11) scheduled
−$616.53K
243,392
$934.63K
Scimeca Dario
General Counsel and Secretary
$169.10K (13) scheduled
−$169.10K
56,457
$216.79K
SMITH J. JEFFERSON
Chief Research Officer
$122.59K (7) scheduled
−$122.59K
121,926
$468.20K
YAO TONY DUNG LING
Director
$100.03K (1)
+$100.03K
166,903
$640.91K
Buehler Kevin
Director
$63.32K (3)
+$63.32K
49,137
$188.69K
Germano Geno J
Director
$47.57K (3)
+$47.57K
44,883
$172.35K
List Alan
Chief Medical Officer
$45.73K (6)
−$45.73K
4,488
$17.23K
Kelly John Alexander
Chief Financial Officer
$209.27K (7)
$164.22K (4) scheduled
+$45.05K
125,883
$483.39K
Brown Melinda
Director
$43.13K (5)
+$43.13K
44,346
$170.29K
Heery Christopher
Chief Medical Officer
$30.02K (2)
+$30.02K
2,485
$9.54K
Frankel Stanley
Director
$26.11K (2)
+$26.11K
40,478
$155.44K
+80,856%
ANSARI ABID
Chief Financial Officer
144,401
$554.50K
+6,737%
Schinazi Raymond F
Director
93,048
$357.30K
Pire Shari Lisa
Director
35,028
$134.51K
Barton Shane
VP & Corporate Controller
27,502
$105.61K
Wadsworth Samuel C.
Director
4,202
$16.14K

No percentages here. This company's share count has moved by a factor of 3.6 over the window, from 7,671,059 to 27,601,554 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
SMITH J. JEFFERSON
18 Feb 2026
Chief Research Officer
Sold on a plan
4,925
$3.84
$18.91K
Scimeca Dario
18 Feb 2026
General Counsel and Secretary
Sold on a plan
4,925
$3.84
$18.91K
Kelly John Alexander
18 Feb 2026
Chief Financial Officer
Sold on a plan
8,149
$3.84
$31.29K
Amoroso Michael
18 Feb 2026
President and CEO
Sold on a plan
20,559
$3.84
$78.95K
Amoroso Michael
22 Jan 2026
President and CEO
Sold on a plan
34,799
$4.17
$145.11K
SMITH J. JEFFERSON
21 Jan 2026
Chief Research Officer
Sold after exercise
10,200
$4.03
$41.11K
Kelly John Alexander
21 Jan 2026
Chief Financial Officer
Sold on a plan
15,213
$4.03
$61.31K
Scimeca Dario
21 Jan 2026
General Counsel and Secretary
Sold on a plan
8,854
$4.03
$35.68K
Frankel Stanley
16 Dec 2025
Director
Buy
2,700
$4.70
$12.69K
Germano Geno J
16 Dec 2025
Director
Buy
3,000
$4.72
$14.16K
Brown Melinda
15 Dec 2025
Director
Buy
1,381
$4.97
$6.86K
Amoroso Michael
3 Nov 2025
President and CEO
Sold after exercise
3,409
$6.49
$22.12K
Scimeca Dario
3 Nov 2025
General Counsel and Secretary
Sold on a plan
665
$6.49
$4.32K
Kelly John Alexander
3 Nov 2025
Chief Financial Officer
Sold on a plan
1,303
$6.49
$8.46K
Frankel Stanley
26 Sep 2025
Director
Buy
2,700
$4.97
$13.42K
Brown Melinda
22 Sep 2025
Director
Buy
1,400
$4.89
$6.85K
Kelly John Alexander
3 Jul 2025
Chief Financial Officer
Sold on a plan
14,827
$4.26
$63.16K
Buehler Kevin
25 Jun 2025
Director
Buy
5,076
$4.16
$21.12K
Brown Melinda
25 Jun 2025
Director
Buy
1,682
$4.14
$6.96K
Brown Melinda
26 Mar 2025
Director
Buy
1,839
$4.75
$8.74K
Buehler Kevin
26 Mar 2025
Director
Buy
4,523
$4.67
$21.12K
Germano Geno J
25 Mar 2025
Director
Buy
3,250
$5.30
$17.23K
Amoroso Michael
24 Mar 2025
President and CEO
Sold on a plan
964
$5.56
$5.36K
Scimeca Dario
4 Mar 2025
General Counsel and Secretary
Sold on a plan
272
$4.91
$1.34K
SMITH J. JEFFERSON
4 Mar 2025
Chief Research Officer
Sold on a plan
154
$4.91
$756.14
SMITH J. JEFFERSON
22 Jan 2025
Chief Research Officer
Sold on a plan
10,287
$4.79
$49.27K
Scimeca Dario
22 Jan 2025
General Counsel and Secretary
Sold on a plan
8,928
$4.79
$42.77K
Amoroso Michael
21 Jan 2025
President and CEO
Sold on a plan
36,838
$4.67
$172.03K
Germano Geno J
30 Dec 2024
Director
Buy
3,605
$4.49
$16.19K
Kelly John Alexander
27 Dec 2024
Chief Financial Officer
Buy
2,113
$4.75
$10.04K
Buehler Kevin
27 Dec 2024
Director
Buy
4,320
$4.88
$21.08K
Brown Melinda
26 Dec 2024
Director
Buy
3,016
$4.55
$13.72K
Kelly John Alexander
21 Nov 2024
Chief Financial Officer
Buy
3,000
$6.76
$20.28K
Amoroso Michael
4 Nov 2024
President and CEO
Sell
3,012
$8.19
$24.67K
Scimeca Dario
4 Nov 2024
General Counsel and Secretary
Sold on a plan
588
$8.19
$4.82K
SMITH J. JEFFERSON
10 Jun 2024
Chief Research Officer
Sell
50
$11.79
$589.50
Scimeca Dario
10 Jun 2024
General Counsel and Secretary
Sold on a plan
93
$11.79
$1.10K
Amoroso Michael
2 May 2024
President and CEO
Sell
1,526
$10.32
$15.75K
List Alan
2 May 2024
Chief Medical Officer
Sell
290
$10.32
$2.99K
SMITH J. JEFFERSON
2 May 2024
Chief Research Officer
Sell
154
$10.32
$1.59K
Scimeca Dario
2 May 2024
General Counsel and Secretary
Sold on a plan
272
$10.32
$2.81K
List Alan
30 Apr 2024
Chief Medical Officer
Sell
238
$10.03
$2.39K
SMITH J. JEFFERSON
23 Jan 2024
Chief Research Officer
Sell
28,000
$0.37
$10.36K
List Alan
22 Jan 2024
Chief Medical Officer
Sold on a plan
21,526
$0.36
$7.75K
Scimeca Dario
22 Jan 2024
General Counsel and Secretary
Sold on a plan
21,287
$0.36
$7.66K
Amoroso Michael
22 Jan 2024
President and CEO
Sold on a plan
137,390
$0.36
$49.46K
Amoroso Michael
3 Nov 2023
President and CEO
Sold on a plan
125,025
$0.40
$50.01K
Scimeca Dario
3 Nov 2023
General Counsel and Secretary
Sold on a plan
16,023
$0.40
$6.41K
Scimeca Dario
8 Jun 2023
General Counsel and Secretary
Sold on a plan
13,361
$0.75
$10.02K
List Alan
27 Apr 2023
Chief Medical Officer
Sold on a plan
7,771
$0.79
$6.14K
Amoroso Michael
22 Mar 2023
President and CEO
Sold on a plan
46,999
$0.82
$38.54K
Kelly John Alexander
17 Mar 2023
Chief Financial Officer
Buy
20,000
$0.86
$17.20K
List Alan
6 Mar 2023
Chief Medical Officer
Sell
9,473
$1.07
$10.14K
Scimeca Dario
6 Mar 2023
General Counsel and Secretary
Sell
12,172
$1.07
$13.02K
Amoroso Michael
17 Oct 2022
President and CEO
Sell
11,006
$1.32
$14.53K
Kelly John Alexander
23 Sep 2022
Chief Financial Officer
Buy
8,200
$1.23
$10.09K
Kelly John Alexander
22 Sep 2022
Chief Financial Officer
Buy
37,037
$1.34
$49.63K
Kelly John Alexander
22 Jun 2022
Chief Financial Officer
Buy
33,784
$1.50
$50.68K
Scimeca Dario
8 Jun 2022
General Counsel and Secretary
Sell
9,833
$2.06
$20.26K
JANTZ DEREK
8 Jun 2022
Chief Scientific Officer
Sell
18,849
$2.06
$38.83K
List Alan
27 Apr 2022
Chief Medical Officer
Sell
7,775
$2.10
$16.33K
Kelly John Alexander
17 Mar 2022
Chief Financial Officer
Buy
16,677
$3.08
$51.37K
THOMSON DAVID S.
23 Jun 2021
Chief Operating Officer
Sold after exercise
30,000
$10.65
$319.50K
THOMSON DAVID S.
21 Jun 2021
Chief Operating Officer
Sold after exercise
15,000
$10.77
$161.55K
THOMSON DAVID S.
18 Jun 2021
Chief Operating Officer
Sold after exercise
10,000
$11.00
$110.00K
THOMSON DAVID S.
17 Jun 2021
Chief Operating Officer
Sold after exercise
10,000
$10.44
$104.40K
THOMSON DAVID S.
15 Jun 2021
Chief Operating Officer
Sold after exercise
2,858
$11.20
$32.01K
THOMSON DAVID S.
11 Jun 2021
Chief Operating Officer
Sold after exercise
30,000
$11.52
$345.60K
JANTZ DEREK
17 May 2021
Chief Scientific Officer
Sell
20,000
$9.38
$187.60K
JANTZ DEREK
14 May 2021
Chief Scientific Officer
Sold after exercise
9,673
$9.17
$88.70K
JANTZ DEREK
13 May 2021
Chief Scientific Officer
Sold after exercise
9,673
$9.15
$88.51K
KANE MATTHEW R.
13 May 2021
President and CEO
Sold after exercise
9,675
$8.96
$86.69K
JANTZ DEREK
12 May 2021
Chief Scientific Officer
Sold after exercise
9,676
$8.72
$84.37K
KANE MATTHEW R.
10 May 2021
President and CEO
Sold after exercise
9,746
$8.25
$80.40K
KANE MATTHEW R.
7 May 2021
President and CEO
Sold after exercise
9,742
$8.57
$83.49K
KANE MATTHEW R.
21 Apr 2021
President and CEO
Exercised, kept
13,422
$1.18
$15.84K
JANTZ DEREK
19 Apr 2021
Chief Scientific Officer
Sold after exercise
9,676
$8.69
$84.08K
JANTZ DEREK
16 Apr 2021
Chief Scientific Officer
Sold after exercise
9,675
$8.84
$85.53K
JANTZ DEREK
15 Apr 2021
Chief Scientific Officer
Sold after exercise
9,676
$8.76
$84.76K
KANE MATTHEW R.
12 Apr 2021
President and CEO
Sold after exercise
9,741
$8.67
$84.45K
KANE MATTHEW R.
9 Apr 2021
President and CEO
Sold after exercise
9,737
$8.87
$86.37K
KANE MATTHEW R.
8 Apr 2021
President and CEO
Sold after exercise
9,736
$9.00
$87.62K
JANTZ DEREK
18 Mar 2021
Chief Scientific Officer
Sold after exercise
9,665
$11.08
$107.09K
JANTZ DEREK
17 Mar 2021
Chief Scientific Officer
Sold after exercise
9,665
$10.92
$105.54K
JANTZ DEREK
16 Mar 2021
Chief Scientific Officer
Sold after exercise
9,661
$11.97
$115.64K
KANE MATTHEW R.
12 Mar 2021
President and CEO
Sold after exercise
9,712
$11.36
$110.33K
KANE MATTHEW R.
11 Mar 2021
President and CEO
Sold after exercise
9,711
$11.38
$110.51K
KANE MATTHEW R.
10 Mar 2021
President and CEO
Sold after exercise
9,710
$11.79
$114.48K
JANTZ DEREK
22 Feb 2021
Chief Scientific Officer
Sold after exercise
9,660
$12.04
$116.31K
JANTZ DEREK
19 Feb 2021
Chief Scientific Officer
Sold after exercise
9,663
$11.55
$111.61K
KANE MATTHEW R.
18 Feb 2021
President and CEO
Sold after exercise
9,705
$12.23
$118.69K
JANTZ DEREK
18 Feb 2021
Chief Scientific Officer
Sold after exercise
6,871
$12.20
$83.83K
KANE MATTHEW R.
17 Feb 2021
President and CEO
Sold after exercise
9,705
$12.28
$119.18K
KANE MATTHEW R.
16 Feb 2021
President and CEO
Sold after exercise
9,697
$13.30
$128.97K
JANTZ DEREK
29 Jan 2021
Chief Scientific Officer
Sold after exercise
6,444
$12.25
$78.94K
JANTZ DEREK
28 Jan 2021
Chief Scientific Officer
Sold after exercise
6,444
$11.97
$77.13K
JANTZ DEREK
27 Jan 2021
Chief Scientific Officer
Sold after exercise
7,048
$11.68
$82.32K
KANE MATTHEW R.
26 Jan 2021
President and CEO
Sold after exercise
9,697
$13.37
$129.65K
KANE MATTHEW R.
25 Jan 2021
President and CEO
Sold after exercise
9,695
$13.74
$133.21K
KANE MATTHEW R.
22 Jan 2021
President and CEO
Sold after exercise
10,218
$13.53
$138.25K
THOMSON DAVID S.
21 Jan 2021
Chief Operating Officer
Sell
10,000
$16.49
$164.90K
ANSARI ABID
15 Jun 2020
Chief Financial Officer
Exercised, kept
8,783
$1.20
$10.54K
ANSARI ABID
15 May 2020
Chief Financial Officer
Exercised, kept
878
$1.18
$1.04K
ANSARI ABID
15 May 2020
Chief Financial Officer
Exercised, kept
8,783
$1.20
$10.54K
JANTZ DEREK
14 Apr 2020
Chief Scientific Officer
Exercised, kept
4,392
$1.18
$5.18K
ANSARI ABID
6 Jan 2020
Chief Financial Officer
Exercised, kept
2,634
$1.18
$3.11K
ANSARI ABID
6 Jan 2020
Chief Financial Officer
Exercised, kept
17,566
$1.20
$21.08K
Heery Christopher
19 Dec 2019
Chief Medical Officer
Buy
2,235
$12.08
$27.00K
Heery Christopher
19 Dec 2019
Chief Medical Officer
Buy
250
$12.09
$3.02K
KANE MATTHEW R.
23 Sep 2019
President and CEO
Exercised, kept
10,000
$1.18
$11.80K
JANTZ DEREK
10 Sep 2019
Chief Scientific Officer
Exercised, kept
13,176
$1.18
$15.55K
THOMSON DAVID S.
10 Jun 2019
Chief Development Officer
Exercised, kept
117,113
$1.18
$138.19K
ANSARI ABID
10 Jun 2019
Chief Financial Officer
Exercised, kept
7,027
$1.18
$8.29K
ANSARI ABID
10 Jun 2019
Chief Financial Officer
Exercised, kept
96,618
$1.20
$115.94K
YAO TONY DUNG LING
3 Apr 2019
Director
Buy indirect
6,487
$15.42
$100.03K
venBio Global Strategic Fund, L.P.
1 Apr 2019
Director
Buy indirect
50,000
$16.00
$800.00K
Schinazi Raymond F
1 Apr 2019
Director
Exercised, kept indirect
36,946
$13.60
$502.47K
YAO TONY DUNG LING
1 Apr 2019
Director
Exercised, kept indirect
36,946
$13.60
$502.47K
FMR LLC
1 Apr 2019
See Remark 1
Buy indirect
50,000
$16.00
$800.00K

What was left out

Form 4 filings counted 235
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 38
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 11,715,028
Sales filed before the plan box existed 8
History held since 29 Mar 2019